Skip to content
Kalpvruksh Markets
Offline Log in

SUMICHEMNSEOffline

SUMITOMO CHEMICAL · INE258G01013 · Small Cap · #338
327.85−0.25 (−0.08%)last close · 05 Nov 2026
Prev close
328.10
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹21,537 cr
52-week range · to 05 Nov 2026313.9564.95

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

SUMICHEM is 42% below its 52-week high, below its 200-day average, behind Chemicals by 29.1 pts over 3 months — a Small Cap company, #338 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • below its 20 / 50 / 200-day averages · 42% below its 52-week high
  • behind its industry by 29.1 pts over 3 months · rank 22 of 26 in Chemicals · −34.0% vs Nifty 500
  • traded value 2.2× usual · delivery 50% vs 50% usual
  • FPI −0.1 pp · DII +0.3 pp · MF schemes in Sept 2026: 14 bought, 35 cut · no promoter pledge · quarter ended 2026-09-30
  • Sept 2026 quarter: profit −12% year on year · revenue −2%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹21,537 cr
Rank
#338
Cap band
Small Cap
Nearest cut-off — Mid / Small
−37.01% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
2.1×
median 3,41,837
Delivered
7,03,910
Of volume
58%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week−1.2%−6.7 pts—
1 month−21.6%−25.0 pts−18.7 pts
3 months−35.4%−34.0 pts−29.1 pts
6 months−33.8%−34.1 pts−29.7 pts
1 year−35.6%−33.8 pts—

Industry: Chemicals (Nifty 500 classification) · rank 22 of 26 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
−10.7%
below
vs 50-day average
−23.6%
below
vs 200-day average
−26.7%
below
ATR (14)
4.2%
typical daily range
Volatility
36%
1 month, annualised
Beta
1.21
vs Nifty 500, 1 year
Traded value
2.2×
vs usual
Delivery
50%
usual 50%
From the 52-week high
−42.0%
place in range 6% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters75.0%75.0%75.0%75.0%
FPI3.4%3.4%3.0% −0.42.9% −0.1
Mutual funds6.5%6.9% +0.37.3% +0.47.7% +0.4
Other DII2.1%2.1%2.1%2.0% −0.1
Individuals9.8%9.7% −0.19.1% −0.59.0% −0.1
Others3.2%3.0% −0.23.5% +0.63.4% −0.1

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
1,09,118
Individuals
1,04,123

Indian passive funds’ stake

2026-06-30

Of free float
0.61%
Of all shares
0.15%
Schemes
41
Days to unwind
1.2
at 100% of volume

7,58,973 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
80
41 index · 39 active
Bought more
38
Sold some
11
FundSharesChangeDid
Tata India Pharma & Healthcare Fund-Reg(G)Active+2,03,822+154.5%bought
Edelweiss Mid Cap Fund-Reg(G)Active+11,28,378+57.9%bought
Kotak Nifty Chemicals ETFIndex+9,431+46.9%bought
Groww Value Fund-Reg(G)Active−15,758−79.5%sold
Canara Rob Value Fund-Reg(G)Active−40,000−13.3%sold
ITI Small Cap Fund-Reg(G)Active−19,553−2.4%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2677311332−1.0%₹1,336 cr
Aug 267673545+1.5%₹1,612 cr
Jul 26741328136+6.4%₹1,567 cr
Jun 2667428128+3.3%₹1,214 cr
May 2671221192−4.1%₹1,400 cr
Apr 267143580+2.0%₹1,220 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the quarter and half-year ended 30th September, 2026.
    26 Oct 2026
  • Board outcome
    Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    27 Jul 2026
  • Board outcome
    Outcome of Board Meeting-XBRL SUMITOMO CHEMICAL INDIA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 26-May-2026 for Dividend
    29 May 2026
  • Board outcome
    Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    27 May 2026

SUMICHEM: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹1.3Final17 Jul 202617 Jul 2026
EarlierDividend₹1.2Final25 Jul 202525 Jul 2025
EarlierDividend₹0.9Final19 Jul 202419 Jul 2024
EarlierDividend₹5Special14 Feb 202414 Feb 2024
EarlierDividend₹1.2Final21 Jul 202321 Jul 2023
EarlierDividend₹1Final21 Jul 202222 Jul 2022

6 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.